DrugCite
Search

COVERSYL

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Coversyl Adverse Events Reported to the FDA Over Time

How are Coversyl adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Coversyl, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Coversyl is flagged as the suspect drug causing the adverse event.

Most Common Coversyl Adverse Events Reported to the FDA

What are the most common Coversyl adverse events reported to the FDA?

Renal Failure Acute
247 (2.53%)
Fall
164 (1.68%)
Hyperkalaemia
154 (1.57%)
Renal Failure
142 (1.45%)
Hypotension
130 (1.33%)
Malaise
126 (1.29%)
Drug Interaction
120 (1.23%)
Pyrexia
120 (1.23%)
Dyspnoea
101 (1.03%)
Cardiac Murmur
99 (1.01%)
Dizziness
99 (1.01%)
Show More Show More
Hypertension
84 (.86%)
Hyponatraemia
84 (.86%)
Urinary Tract Infection
80 (.82%)
Dehydration
79 (.81%)
Atrial Fibrillation
73 (.75%)
Oedema Peripheral
73 (.75%)
Sinus Tachycardia
69 (.71%)
White Blood Cell Count Increased
69 (.71%)
Bradycardia
68 (.7%)
Fatigue
63 (.64%)
Constipation
62 (.63%)
Neutrophil Count Increased
62 (.63%)
Confusional State
61 (.62%)
Thrombocytopenia
61 (.62%)
Drug Ineffective
60 (.61%)
Paraesthesia
60 (.61%)
Vomiting
60 (.61%)
Diabetes Mellitus
59 (.6%)
Diarrhoea
58 (.59%)
Pruritus
58 (.59%)
Skin Disorder
55 (.56%)
Blood Creatinine Increased
54 (.55%)
Cough
54 (.55%)
Hiatus Hernia
54 (.55%)
Iron Deficiency Anaemia
54 (.55%)
Loss Of Consciousness
54 (.55%)
Abdominal Tenderness
53 (.54%)
Angioedema
53 (.54%)
Staphylococcal Infection
53 (.54%)
Asthenia
52 (.53%)
Mean Cell Volume Decreased
52 (.53%)
Nausea
52 (.53%)
Cardiac Failure
51 (.52%)
Body Mass Index Decreased
50 (.51%)
Orthostatic Hypotension
50 (.51%)
Monocyte Count Increased
48 (.49%)
General Physical Health Deteriorati...
47 (.48%)
Eosinophilia
44 (.45%)
Agranulocytosis
42 (.43%)
Metabolic Acidosis
40 (.41%)
Toxic Skin Eruption
40 (.41%)
White Blood Cell Disorder
40 (.41%)
Condition Aggravated
39 (.4%)
Overdose
39 (.4%)
Interstitial Lung Disease
38 (.39%)
Cytolytic Hepatitis
37 (.38%)
Headache
36 (.37%)
Physical Assault
36 (.37%)
Lactic Acidosis
35 (.36%)
Ventricular Tachycardia
35 (.36%)
Feeling Abnormal
34 (.35%)
Hypokalaemia
34 (.35%)
Abdominal Pain
33 (.34%)
Syncope
33 (.34%)
Dysphagia
31 (.32%)
Pancreatitis Acute
31 (.32%)
Rash
31 (.32%)
Weight Decreased
31 (.32%)
International Normalised Ratio Incr...
29 (.3%)
Venous Pressure Jugular Increased
29 (.3%)
Cardiac Arrest
28 (.29%)
Myalgia
28 (.29%)
Renal Impairment
28 (.29%)
Coma
27 (.28%)
Decreased Appetite
27 (.28%)
Rhabdomyolysis
27 (.28%)
Cholestasis
26 (.27%)
Dyspnoea Exertional
26 (.27%)
Hypoglycaemia
26 (.27%)
Left Ventricular Dysfunction
26 (.27%)
Oedema
25 (.26%)
Pemphigoid
25 (.26%)
Leukocytosis
24 (.25%)
Alanine Aminotransferase Increased
23 (.24%)
Aspartate Aminotransferase Increase...
23 (.24%)
Blood Urea Increased
23 (.24%)
Leukopenia
23 (.24%)
Neutropenia
23 (.24%)
Anaemia
22 (.22%)
Anorexia
22 (.22%)
Aortic Dissection
22 (.22%)
Blood Pressure Increased
22 (.22%)
Drug Rash With Eosinophilia And Sys...
22 (.22%)
Epistaxis
22 (.22%)
Haemoptysis
22 (.22%)
Dissociation
21 (.21%)
Erythema
21 (.21%)
Haematoma
21 (.21%)
Heart Rate Increased
21 (.21%)
Hyperhidrosis
21 (.21%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Coversyl, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Coversyl is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Coversyl

What are the most common Coversyl adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Coversyl, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Coversyl is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Coversyl According to Those Reporting Adverse Events

Why are people taking Coversyl, according to those reporting adverse events to the FDA?

Hypertension
1515
Drug Use For Unknown Indication
548
Product Used For Unknown Indication
374
Ill-defined Disorder
205
Essential Hypertension
123
Cardiac Failure
107
Show More Show More
Cardiac Failure Congestive
79
Blood Pressure
38
Myocardial Ischaemia
36
Prophylaxis
36
Myocardial Infarction
30
Blood Pressure Increased
20
Coronary Artery Disease
15
Congestive Cardiomyopathy
14
Atrial Fibrillation
13
Angina Pectoris
11
Cardiac Disorder
11
Cardiac Failure Chronic
10
Unevaluable Event
10
Cerebrovascular Accident
8
Ischaemic Cardiomyopathy
8
Cerebrovascular Accident Prophylaxi...
8
Acute Myocardial Infarction
7
Maternal Exposure Timing Unspecifie...
7
Nephropathy
7
Cardiomyopathy
7
Blood Pressure Abnormal
7
Drug Exposure During Pregnancy
6
Left Ventricular Failure
5
Blood Pressure Management
5
Hypertensive Heart Disease
5
Cardiovascular Disorder
5
Aortic Bypass
5
Cardiovascular Event Prophylaxis
5
Ejection Fraction Decreased
5
Thrombosis Prophylaxis
5
Renal Disorder
4
Diabetic Nephropathy
4
Renal Failure Chronic
3
Acute Coronary Syndrome
3
Microalbuminuria
3
Transient Ischaemic Attack
3
Anticoagulant Therapy
3
Chest Pain
3
Peripheral Vascular Disorder
3
Ischaemic Heart Disease Prophylaxis
2
Pulmonary Arterial Hypertension
2
Intentional Overdose
2
Gout
2
Hypotension
2
Hiv Infection
2

Coversyl Case Reports

What Coversyl safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Coversyl. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Coversyl.